Berlin, Germany

Christoph Kneip

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christoph Kneip: Innovator in Tumor Molecular Subtyping

Introduction

Christoph Kneip is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of cancer research, particularly in the molecular subtyping of tumors. His work aims to improve the treatment and stratification of cancer patients based on their tumor characteristics.

Latest Patents

Kneip holds a patent for "Methods and kits for the molecular subtyping of tumors." This invention relates to an in vitro method of identifying a molecular subtype of a tumor in a cancer patient. It also includes a method for stratifying a cancer patient for tumor treatment. Additionally, the patent encompasses kits that are useful for identifying a molecular subtype of a tumor in a cancer patient. He has 1 patent to his name.

Career Highlights

Throughout his career, Christoph Kneip has worked with prominent companies in the biotechnology sector. Notably, he has been associated with BioNTech Diagnostics GmbH and Stratifyer Molecular Pathology GmbH. His experience in these organizations has allowed him to contribute to advancements in molecular pathology and cancer diagnostics.

Collaborations

Kneip has collaborated with various professionals in his field, including Ralph Markus Wirtz. Their joint efforts have furthered research and development in tumor molecular subtyping.

Conclusion

Christoph Kneip's innovative work in the molecular subtyping of tumors represents a significant advancement in cancer treatment. His contributions through patents and collaborations continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…